HSP90 INHIBITORS POTENTIALLY OVERCOME CHEMORADIOTHERAPY RESISTANCE ASSOCIATED WITH HER2 AND NFfEB OVEREXPRESSION IN MIBC

被引：0
|
作者：
Yoshida, Soichiro
Koga, Fumitaka
Tatokoro, Manabu
Kawakami, Satoru
Fujii, Yasuhisa
Kumagai, Jiro
Neckers, Len
Kihara, Kazunori
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.1091
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1054
引用
收藏
页码：E424 / E424
页数：1
相关论文
共 50 条
  • [41] The Hsp90 inhibitor IPI-504 inhibits proliferation and tumor growth of HER2 overexpressing breast cancer cells with acquired trastuzumab resistance
    Scaltriti, Maurizio
    Guzman, Marta
    Normant, Emmanuel
    Jimenez, Jose
    Prudkin, Ludmila
    Aura, Claudia
    Baselga, Jose
    CANCER RESEARCH, 2009, 69
  • [42] Effects of Alkanna bracteosa extract on the expression level of HSP90α and HER2 genes in human gastric cancer cell line
    Mina Gholami
    Zahra Elyasigorji
    Abdolreza Daneshvar Amoli
    Parvaneh Farzaneh
    Advances in Traditional Medicine, 2023, 23 : 877 - 886
  • [43] Early tumor response to Hsp90 therapy using HER2 PET:: Comparison with 18F-FDG PET
    Smith-Jones, PM
    Solit, D
    Afroze, F
    Rosen, N
    Larson, SM
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (05) : 793 - 796
  • [44] Phamacodynamic Immuno-PET imaging of HSP90 inhibitor on HER2 expression with 64Cu-NOTA-Trastuzumab
    Lee, T.
    Hwang, Y.
    Jeong, I.
    Kim, K.
    Lee, Y.
    Kang, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S686 - S686
  • [45] Effects of Alkanna bracteosa extract on the expression level of HSP90α and HER2 genes in human gastric cancer cell line
    Gholami, Mina
    Elyasigorji, Zahra
    Amoli, Abdolreza Daneshvar
    Farzaneh, Parvaneh
    ADVANCES IN TRADITIONAL MEDICINE, 2023, 23 (03) : 877 - 886
  • [46] Newer-Generation HSP90 Inhibitors Can Overcome Ibrutinib Resistance and Suppress Proliferation in Human Mantle Cell Lymphoma in Vitro and in Vivo
    Kopp, Nadja
    Tschuri, Sebastian
    Haebe, Sarah
    van Bodegom, Diederik
    Bird, Liat
    Christie, Amanda L.
    Saur, Amy
    Christodoulou, Alexandra N.
    Tivey, Trevor
    Kung, Andrew L.
    Weigert, Oliver
    Weinstock, David
    BLOOD, 2014, 124 (21)
  • [47] VRN10s, a series of HER2 inhibitors to overcome NRG-mediated drug resistance and acquired-drug resistant HER2 mutations
    Park, Chan Mi
    Yoo, Jihye
    Son, Mingyeong
    Jung, Hong-Ryul
    Park, Jin-Hee
    Son, Jeongbum
    Ko, Eunhwa
    Kim, Sunghwan
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [48] HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer
    R Schulz
    F Streller
    A H Scheel
    J Rüschoff
    M-C Reinert
    M Dobbelstein
    N D Marchenko
    U M Moll
    Cell Death & Disease, 2014, 5 : e980 - e980
  • [49] HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer
    Schulz, R.
    Streller, F.
    Scheel, A. H.
    Rueschoff, J.
    Reinert, M-C
    Dobbelstein, M.
    Marchenko, N. D.
    Moll, U. M.
    CELL DEATH & DISEASE, 2014, 5 : e980 - e980
  • [50] Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
    Chandarlapaty, S.
    Scaltriti, M.
    Angelini, P.
    Ye, Q.
    Guzman, M.
    Hudis, C. A.
    Norton, L.
    Solit, D. B.
    Arribas, J.
    Baselga, J.
    Rosen, N.
    ONCOGENE, 2010, 29 (03) : 325 - 334
12345